Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study
1997

Hepatitis B and C Virus Infection and Liver Cancer Risk

Sample size: 400 publication Evidence: high

Author Information

Author(s): JF Tsai, JE Jeng, MS Ho, WY Chang, MY Hsieh, ZY Lin, JH Tsai

Primary Institution: Kaohsiung Medical College

Hypothesis

Is there an additive effect between chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection on the development of hepatocellular carcinoma (HCC)?

Conclusion

The study found that co-infection with HBV and HCV significantly increases the risk of developing hepatocellular carcinoma.

Supporting Evidence

  • 80 out of 400 patients developed HCC during the study.
  • The annual incidence of HCC was 6.8% among the cohort.
  • Patients co-infected with HBV and HCV had a 13.3% annual incidence of HCC.
  • Patients with anti-HCV alone had a 7.0% annual incidence of HCC.
  • Patients with HBsAg alone had a 6.6% annual incidence of HCC.
  • Patients without either marker had a 2.0% annual incidence of HCC.
  • Multivariate analysis showed that co-infection was an independent risk factor for HCC.

Takeaway

If someone has both hepatitis B and C, they are more likely to get liver cancer than if they only have one of the viruses.

Methodology

This was a prospective study following 400 cirrhotic patients for the development of HCC, with regular monitoring of liver function and viral markers.

Limitations

The study had a loss to follow-up of 10.5% of patients, which may affect the results.

Participant Demographics

The cohort consisted of 290 men and 110 women, with a mean age of 52 years.

Statistical Information

P-Value

p<0.0001

Confidence Interval

95% CI, 1.80-22.80

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication